Spots Global Cancer Trial Database for consolidation chemotherapy
Every month we try and update this database with for consolidation chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | NCT05026229 | Precursor Cell ... Philadelphia-Po... ALL, Adult | dasatinib plus ... dasatinib plus ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence | NCT05054959 | Locally Advance... | consolidation c... induction chemo... | 18 Years - | Institute of Oncology Ljubljana | |
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait | NCT05000697 | Rectal Cancer Consolidation | Oxaliplatin 5FU | 18 Years - | Hospital Alemão Oswaldo Cruz | |
Leukemia Stem Cell Detection in Acute Myeloid Leukemia | NCT02927938 | Acute Myeloid L... | Allogeneic HCT Consolidation c... | 18 Years - | Wake Forest University Health Sciences | |
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00094861 | Dysphagia Non-Small Cell ... Lung Cancer | Palifermin Placebo Radiotherapy Paclitaxel Carboplatin | 18 Years - | Swedish Orphan Biovitrum | |
Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy | NCT02843191 | Rectal Cancer | Chemotherapy | 20 Years - 75 Years | Kyung Hee University Hospital at Gangdong | |
Leukemia Stem Cell Detection in Acute Myeloid Leukemia | NCT02927938 | Acute Myeloid L... | Allogeneic HCT Consolidation c... | 18 Years - | Wake Forest University Health Sciences | |
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer | NCT05274945 | Rectal Cancer | Radiotherapy consolidation c... TME or APR | 18 Years - 75 Years | Alexandria University | |
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia | NCT01297543 | Acute Myeloid L... Acute Lymphobla... Chronic Myeloid... Myelodysplasia | human myeloid p... G-CSF | 18 Years - | Cellerant Therapeutics | |
Total Neoadjuvant Therapy in Rectal Cancer Treatment | NCT04747951 | Rectal Cancer | Concurrent Chem... TME consolidation c... adjuvant chemot... | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
Leukemia Stem Cell Detection in Acute Myeloid Leukemia | NCT02927938 | Acute Myeloid L... | Allogeneic HCT Consolidation c... | 18 Years - | Wake Forest University Health Sciences | |
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk | NCT04664504 | Rectal Cancer | Concurrent Chem... Short-course Ra... Local dose incr... Consolidation c... Adjuvant chemot... TME | 18 Years - 75 Years | ChineseAMS | |
Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer | NCT00210171 | Carcinoma, Non-... | Toxicity : Time... | 18 Years - 70 Years | Institut Bergonié | |
Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer | NCT05673772 | Rectal Cancer | short-course ra... mFOLFOX6 Chemoradiothera... TME surgery | 20 Years - 75 Years | Kyungpook National University Hospital | |
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) | NCT02668653 | Acute Myeloid L... Leukemia | Chemotherapy Quizartinib Placebo | 18 Years - 75 Years | Daiichi Sankyo | |
Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer | NCT04135313 | Rectal Neoplasm... Rectum Carcinom... Rectal Cancer | Capecitabine Oxaliplatin Capecitabine Radiotherapy Rectal cancer s... | 18 Years - 75 Years | Blokhin's Russian Cancer Research Center | |
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence | NCT05054959 | Locally Advance... | consolidation c... induction chemo... | 18 Years - | Institute of Oncology Ljubljana | |
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia | NCT01297543 | Acute Myeloid L... Acute Lymphobla... Chronic Myeloid... Myelodysplasia | human myeloid p... G-CSF | 18 Years - | Cellerant Therapeutics | |
Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer | NCT06417476 | Rectal Neoplasm... | Short-course ra... Irinotecan Oxaliplatin Calcium Formate Fluorouracil Long-course che... Capecitabine | 18 Years - 70 Years | Sun Yat-sen University | |
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) | NCT02668653 | Acute Myeloid L... Leukemia | Chemotherapy Quizartinib Placebo | 18 Years - 75 Years | Daiichi Sankyo | |
Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer | NCT05673772 | Rectal Cancer | short-course ra... mFOLFOX6 Chemoradiothera... TME surgery | 20 Years - 75 Years | Kyungpook National University Hospital | |
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | NCT05026229 | Precursor Cell ... Philadelphia-Po... ALL, Adult | dasatinib plus ... dasatinib plus ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL | NCT05026229 | Precursor Cell ... Philadelphia-Po... ALL, Adult | dasatinib plus ... dasatinib plus ... | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait | NCT05000697 | Rectal Cancer Consolidation | Oxaliplatin 5FU | 18 Years - | Hospital Alemão Oswaldo Cruz | |
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer | NCT05274945 | Rectal Cancer | Radiotherapy consolidation c... TME or APR | 18 Years - 75 Years | Alexandria University |